(Q44199606)

30 November 2017

title

Nonalcoholic steatohepatitis and increased risk of chronic kidney disease (English)

1 reference

30 November 2017

0 references

10

Toshikazu Yoshikawa

1 reference

30 November 2017

Kohichiroh Yasui

1

1 reference

30 November 2017

Yoshio Sumida

2

1 reference

30 November 2017

Yasukiyo Mori

3

1 reference

30 November 2017

Hironori Mitsuyoshi

4

1 reference

30 November 2017

Masahito Minami

5

1 reference

30 November 2017

Yoshito Itoh

6

1 reference

30 November 2017

Kazuyuki Kanemasa

7

1 reference

30 November 2017

Hiroaki Matsubara

8

1 reference

30 November 2017

Takeshi Okanoue

9

1 reference

30 November 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20817213

6 July 2024

publication date

3 September 2010

1 reference

full work available at URL

30 November 2017

https://api.elsevier.com/content/article/PII:S0026049510002507?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

https://api.elsevier.com/content/article/PII:S0026049510002507?httpAccept=text/plain

6 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

6 July 2024

1 reference

30 November 2017

volume

60

1 reference

30 November 2017

issue

5

1 reference

30 November 2017

page(s)

735-739

1 reference

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

30 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

6 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

Nonalcoholic steatohepatitis: An expanded clinical entity

6 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey

6 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

6 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

6 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

6 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

Impact of treating the metabolic syndrome on chronic kidney disease

6 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

Insulin resistance and risk of chronic kidney disease in nondiabetic US adults

6 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?

6 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

Nonalcoholic fatty liver disease

6 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

Cardiometabolic syndrome and chronic kidney disease

6 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

6 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

6 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.

6 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

6 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

Revised equations for estimated GFR from serum creatinine in Japan

6 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification

6 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

6 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

Long-term follow-up of patients with nonalcoholic fatty liver

6 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients

6 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

The metabolic syndrome and chronic kidney disease in U.S. adults

6 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease

6 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men.

6 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis

6 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

Non-alcoholic fatty liver disease and increased risk of cardiovascular disease

6 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.07.022

6 July 2024

Identifiers

1 reference

30 November 2017

1 reference